Similar drugsTo uncover
Dosage form: & nbspcoated tablets
Composition:

1 tablet, coated, contains:

Active substances:

Retinol nalmitate concentrate1) (vitamin A), synthetic, oily form (1.7 MIU / g) 0.35 mg

Colocalciferol concentrate2), an oily form (vitamin D3) (1 MIU / g) 0.08 mg

Ascorbic acid (vitamin C) 10.00 mg

Thiamine mononitrate (vitamin B1) 0.25 mg

Riboflavin (vitamin B2) 0.30 mg

Pyridoxine hydrochloride (vitamin B6) 0.30 mg

Cyanocobalamin 0.1% in mannitol (E421) (vitamin B12) 0.20 mg

Nicotinamide 3.00 mg

Folic acid 0.04 mg

Calcium paMr.thienate 1.20 mg

Calcium hydrophosphate (anhydrous) 43.00 mg

Excipients: lactose monohydrate 192.00 mg, flavoring orange oil 05073 5.00 mg, polysorbate 80 1.00 mg, glycerol 5.50 mg, castor oil 1.60 mg, citric acid, anhydrous 13.72 mg, sorbitol (E420) 134 , 20 mg, dextrose (glucose liquid) (dry matter) 160.00 mg, magnesium stearate 2.50 mg, Capol 600 Pharma 2.50 mg, petroleum jelly 10.00 mg, povidone K-25 2.00 mg, dimethicone (defoamer 1510) (E900) 0.01 mg, sucrose to 1200.00 mg

1 tablet, covered with a shell, intensely pink color additionally contains: dye crimson [Ponso 4R] (E124) 0.20 mg, titanium dioxide (E171) 3.00 mg 1 tablet coated with a yellow color additionally contains: dye sunset yellow 06080 (E110) 0.04 mg, quinoline yellow (E104) dye 0.30 mg, titanium dioxide (E171) 4.00 mg

1 tablet, coated with an orange color, additionally contains: dye sunset yellow 06080 (E1 10) 0.50 mg, titanium dioxide (E171) 4.00 mg

1 tablet coated with a green color additionally contains: indigo carmine dye (E132) 0.015 mg, quinoline yellow (E104) dye 0.10 mg, titanium dioxide (E171) 4.00 mg

1) retinol palmitate concentrate contains: retinol palmitate, bugylhydroxyanisole and bugylhydroxytoluene.

2) The colcalciferol concentrate contains: colcalciferol, DL-α-tocopherol and triglycerides of medium chain fatty acids.

Description:

Round, biconvex tablets, covered with a coat of intensely pink, yellow, green and orange. Inclusions are allowed.

Pharmacotherapeutic group:multivitamin
ATX: & nbsp
  • Multivitamins with minerals
  • Pharmacodynamics:

    A combined preparation containing a complex of vitamins and minerals, which are important factors in metabolic processes.

    Vitamin A participates in the synthesis of various substances (proteins, lipids, mucopolysaccharides) and provides a normal function of the skin, mucous membranes, as well as the organ of vision.

    Vitamin D3 plays an important role in maintaining the balance of calcium and phosphorus in the body.

    Vitamin B1normalizes the activity of the heart and promotes the normal functioning of the nervous system.

    Vitamin B2 promotes the processes of tissue regeneration, including skin cells.

    Vitamin B6 helps maintain the structure and function of bones, teeth, gums, affects erythropoiesis, promotes the normal functioning of the nervous system.

    Vitamin B12 participates in erythropoiesis, promotes the normal functioning of the nervous system.

    Vitamin B5 (calcium pantothenate) is part of coenzyme A, which plays an important role in the processes of acetylation and oxidation. Activates metabolic processes in tissues.

    Vitamins of group B are involved in the formation of various enzymes that regulate the metabolism in the body.

    Vitamin C participates in the oxidation of a number of biologically active substances, regulation of metabolism in connective tissue, carbohydrate metabolism, blood coagulability and tissue regeneration, stimulates the formation of steroid hormones, normalizes the permeability of capillaries. Vitamin C increases the body's resistance to infections, reduces inflammatory reactions.

    Vitamin PP (nicotinamide) - coenzyme involved in the metabolism of protein, in the synthesis of fatty acids and cholesterol, in the production of energy, and is necessary for the normal functioning of the central nervous system.

    Folic acid stimulates erythropoiesis.

    Calcium participates in the formation of bone tissue, blood clotting, transmission of nerve impulses, reduction of skeletal and smooth muscles.

    Phosphorus, along with calcium, participates in the formation of bones and teeth, and also participates in the processes of energy metabolism.

    Indications:

    Prevention of deficiency of vitamins and minerals with:

    - Inadequate and unbalanced nutrition;

    - due to lack of appetite;

    - When overworked in school-age children.

    In the complex therapy of diseases accompanied by the appointment of antibiotics.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Hypervitaminosis A and D.

    Children up to 4 years old.

    Congenital intolerance to glucose, fructose, glucose-galactose malabsorption, sugar / isomaltase deficiency.

    Pregnancy and lactation:

    Pregnant and lactating women can take vitamins and minerals on the recommendation of a doctor.Doses of vitamins in the Pikovit® preparation, coated tablets, are intended for children.

    Dosing and Administration:

    Inside, pills Pikovit® should be kept in the mouth until completely dissolved.

    Children aged 4 to 6 years it is recommended to take 1 tablet 4-5 times a day.

    Children aged from 7 under 14 years old it is recommended to take 1 tablet 5-7 times a day.

    The course of taking the drug is 20-30 days. A repeated course of admission on the recommendation of a doctor.

    In the absence of appetite in children, Pikovit® can be given to children for 2 months.

    Side effects:

    Allergic reactions.

    High doses of glycerol can cause headaches, disorders of the gastrointestinal tract (diarrhea).

    Pikovit® contains azo dyes (E124) and (E110), which can cause a hypersensitivity reaction with an asthmatic component. Similar reactions are more often observed in patients with hypersensitivity to acetylsalicylic acid.

    Overdose:

    There were no cases of overdose.

    Symptoms

    Symptoms of hypervitaminosis A after short-term use of large doses of vitamin A are abdominal pain, anorexia, vomiting, visual impairment, headache, uncoordinated movements and redness of the skin.Prolonged use of large doses of vitamin A can cause thinning and itching of the skin, cracks in the lips, conjunctival inflammation, eye damage, joint pain, chronic headache and multiple vomiting.

    Symptoms of hypervitaminosis D, which can occur after applying large doses of vitamin D, are anorexia, weight loss, fatigue, disorientation, vomiting, constipation or diarrhea, metallic taste in the mouth, dryness of the oral mucosa and thirst.

    In order to avoid an overdose, do not exceed the daily dose. Treatment

    If the symptoms of an overdose develop, the use of Pikovit® should be discontinued.

    Treatment is symptomatic. Vomit should be caused and a sufficient amount of liquid should be injected. Limit the intake of calcium and vitamin D from food to prevent hypercalcemia.

    Interaction:

    Pikovit® contains calcium and therefore delays the absorption of antibiotics from the group of trastcyclins in the intestine, as well as antimicrobial agents - derivatives of fluoroquinolones (it is necessary that the interval between preparations is at least 2 hours).Vitamin C enhances the effect and side effects of antimicrobial agents from the group of sulfonamides (including the appearance of crystals in the urine).

    With the simultaneous use of diuretics from the group of thiazides, the likelihood of hypercalcemia increases.

    Special instructions:

    It is possible to stain urine yellow - completely harmless and due to the presence of riboflavin in the preparation.

    It is not recommended to take Pikovit ® together with other preparations containing vitamins and minerals.

    High doses of glycerol can cause headaches, disorders of the gastrointestinal tract (diarrhea).

    Pikovit® contains azo dyes (E124) and (E110), which can cause a hypersensitivity reaction with an asthmatic component. Similar reactions are more often observed in patients with hypersensitivity to acetylsalicylic acid.

    The preparation contains 192 mg of lactose, 611 mg of sucrose, 160 mg of glucose and 134.2 mg of sorbitol, so the drug is not recommended for children with congenital intolerance glucose and fructose, with glucose-galactose malabsorption syndrome and deficiency sucrose / isomaltase.

    Effect on the ability to drive transp. cf. and fur:

    The effect of the drug on the ability to drive vehicles and mechanisms was not reported.

    The drug has no effect on the motor function of children.

    Form release / dosage:

    The tablets covered with a cover.

    Packaging:

    For 15 tablets in a blister of PVC / PE / PVDC with aluminum foil.

    For 2 or 4 blisters in a pack of cardboard along with instructions for use.

    Storage conditions:

    At a temperature of no higher than 25 ° C, in the original packaging.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use the drug after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N013559 / 01
    Date of registration:05.09.2007 / 15.08.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:KRKA, dd, Novo mesto, AOKRKA, dd, Novo mesto, AO
    Manufacturer: & nbsp
    KRKA, d.d. Slovenia
    Representation: & nbspKRKA KRKA Slovenia
    Information update date: & nbsp05.10.2016
    Illustrated instructions
      Instructions
      Up